PCSA · Forms 3, 4, 5
Insider trades at Processa Pharmaceuticals, Inc.
No open-market insider buys or sells at Processa Pharmaceuticals, Inc. in the last 90 days; 11 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Processa Pharmaceuticals, Inc. (PCSA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| George K Ng | Chief Executive Officer | Option exercise | 1,600 | Form 4 | |||
| Sheila Gujrathi | Director | Options or other derivatives | Form 4 | ||||
| Sheila Gujrathi | Director | Became an insider (Form 3) | Form 3 | ||||
| Justin W Yorke | Director | Options or other derivatives | Form 4 | ||||
| Russell Skibsted | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Geraldine Pannu | Director | Options or other derivatives | Form 4 | ||||
| George K Ng | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| James R Neal | Director | Options or other derivatives | Form 4 | ||||
| Patrick Lin | Chief Business - Strategy Off | Options or other derivatives | Form 4 | ||||
| Wendy Guy | Chief Administrative Officer | Options or other derivatives | Form 4 | ||||
| Khoso Baluch | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.